Harpagophytum & Cassis + Reine des prés
Food supplement declared in France, declaration No 2023-12-483, decision dated 12 December 2023
Harpagophytum & Cassis + Reine des prés (Fleurentin) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Harpagophytum procumbens 300 mg per day, Ribes nigrum 100 mg per day, Filipendula ulmaria 40 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Fleurentin
- Food business operator placing the product on the market
- PHARMACIE FLEURENTIN
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2
- Directions for use
- Prendre 2 gélules par jour, à avaler par voie orale avec un verre d'eau
- Intended populations
- People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, Children (under 12), Pregnant women, Taking anticoagulants, Ulcer (stomach or duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Joints
Declaration 329388, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Harpagophytum procumbens | Racine | Extrait sec aqueux | 300 mg |
| Ribes nigrum L. | Feuille | Extrait sec aqueux | 100 mg |
| Filipendula ulmaria (L.) Maxim. | Sommités fleuries | Poudre (de plantes séchées ou broyées) | 40 mg |
Additives
E464, E470b
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Ne pas dépasser la dose journalière recommandée. Ne se substitue pas à un régime alimentaire varié et sera utilisé dans le cadre d'un mode de vie sain. Produit destiné à l'adulte. Ne pas laisser à la portée des jeunes enfants. Déconseillé en cas d'ulcères, de calculs biliaires, et aux personnes souffrant d'allergie aux dérivés salicylés, ou sous anticoagulants.
Regulatory points
- Conditions légales
Filipendula ulmaria (L.) Maxim.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Harpagophytum procumbens
Read the warning, when it applies and the studies cited
DEVIL'S CLAW - HARPAGOPHYTUM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Fleurentin
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Harpagophytum & Cassis + Reine des prés (Fleurentin): composition and regulation”, https://compoatlas.com/en/supplements/products/329388-harpagophytum-cassis-reine-des-pres, updated 15 November 2026.